SELPERCATINIB

Selpercatinib 80 mg tablet, 56

SELPERCATINIB (15494L)

Selpercatinib 80 mg tablet, 56
15494L
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19048)

Indication: Advanced or metastatic medullary thyroid cancer
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 112 # of repeats: 5 DPMQ: $8,213.36 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Retevmo